XML 14 R4.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Income Statement [Abstract]        
Net sales $ 1,979,161 $ 1,086,061 $ 3,921,777 $ 2,061,248
Cost of sales 1,573,327 844,695 3,148,800 1,564,297
Gross profit 405,834 241,366 772,977 496,951
Selling, general and administrative expenses 130,626 53,719 254,277 107,028
Transaction and integration-related costs 8,092 7,709 16,286 7,709
Income (loss) from operations 267,116 179,938 502,414 382,214
Interest Expense (38,972) (5,915) (78,748) (12,600)
Other income (expense)        
Other income (expense), net (538) 8,181 4,533 10,826
Income before income taxes 227,606 182,204 428,199 380,440
Provision for income taxes 68,188 66,584 124,071 135,884
Net income 159,418 115,620 304,128 244,556
Net income attributable to noncontrolling interests 6,591 4,496 13,111 10,304
Net income attributable to Westlake Chemical Corporation $ 152,827 $ 111,124 $ 291,017 $ 234,252
Earnings per common share attributable to Westlake Chemical Corporation:        
Basic (usd per share) $ 1.18 $ 0.85 $ 2.24 $ 1.80
Diluted (usd per share) $ 1.17 $ 0.85 $ 2.23 $ 1.79
Weighted average common shares outstanding:        
Basic (in shares) 129,051,227 129,583,224 129,015,507 129,886,594
Diluted (in shares) 129,786,714 129,980,527 129,739,643 130,290,521
Dividends per common share (usd per share) $ 0.1906 $ 0.1815 $ 0.3812 $ 0.3630